Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire PLC    SHP   JE00B2QKY057

SHIRE PLC (SHP)

Delayed Quote. Delayed  - 08/24 05:35:24 pm
5025 GBp   -0.30%
08/22DJSHIRE : Files 8K - Other Events
08/19 SHIRE : Elections for the interim dividend in ...
08/19 SHIRE : Elections for the interim dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Shire PLC : Shire Buys 50,953 Own Shares to Hold in Treasury

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 09:57am CEST

LONDON--Biopharmaceutical company Shire PLC (SHP.LN), said Friday it purchased 50,953 of its ordinary shares of 5 pence each on February 21, through both direct purchases of Ordinary Shares and through the purchase of Ordinary Shares underlying ADRs.

MAIN FACTS:

-The purchased shares will be held as treasury shares

-The highest and lowest price paid for the directly acquired Ordinary Shares was 2083.00 pence per share and 2047.00 pence per share respectively and for those Ordinary Shares acquired through the purchase of ADRs was 3148.50 cents per share and 3139.33 cents per share respectively.

-Shire shares at 0840 GMT traded up 5.0 pence, or 0.2%, at GBP20.77, valuing the company at GBP11.55 billion.

-Write to Razak Musah Baba at razak.baba@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIRE PLC
08/22DJSHIRE : Files 8K - Other Events
08/22 SHIRE PLC : Financial Statements and Exhibits (form 8-K)
08/19 SHIRE : Elections for the interim dividend in ...
08/19 SHIRE : Elections for the interim dividend
08/18 SHIRE : *exane bnp raises shire price target to 5,900 (5,700) pence - 'outperfor..
08/11 VITAE PHARMACEUTICALS : Appoints Scott Applebaum as General Counsel and Corporat..
08/11 SHIRE PLC : Financial Statements and Exhibits (form 8-K)
08/11DJSHIRE : Files 8K - Other Events
08/09 SHIRE : Vonvendi, the first and only ...
08/08DJSHIRE : Files 8K - Other Events
More news
Sector news : Pharmaceuticals - NEC
08/24DJPFIZER : Buys Part of AstraZeneca's Antibiotics Business -- 2nd Update
08/24DJASTRAZENECA : Sells Part of its Antibiotics Business to Pfizer -- Update
08/24DJPfizer Buys Part of AstraZeneca's Antibiotics Business
08/24DJASTRAZENECA : Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Bill..
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/22 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2016 Update
08/20 Tracking John Paulson's Paulson & Company Portfolio - Q2 2016 Update
08/19 U.S. V. Apple - The Looming Trial Of The Century?
08/18 SHIRE : New Acquisition
08/18 Raptor Pharmaceuticals in play; shares up 16% premarket
Advertisement
Financials ($)
Sales 2016 11 042 M
EBIT 2016 3 836 M
Net income 2016 1 471 M
Debt 2016 19 896 M
Yield 2016 0,43%
P/E ratio 2016 29,00
P/E ratio 2017 16,03
EV / Sales 2016 7,20x
EV / Sales 2017 4,87x
Capitalization 59 603 M
More Financials
Chart SHIRE PLC
Duration : Period :
Shire PLC Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Full-screen chart
Technical analysis trends SHIRE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 80,4 $
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Jeffrey Poulton Chief Financial Officer & Executive Director
Philip J. Vickers Global Head-Research & Development
David R. Ginsburg Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE PLC8.45%59 603
JOHNSON & JOHNSON16.28%326 773
ROCHE HOLDING LTD.-12.26%219 257
NOVARTIS AG-9.97%214 603
PFIZER INC.8.71%212 844
MERCK & CO., INC.20.37%175 812
More Results